Inherited neuropathies: Clinical overview and update

Muscle and Nerve

Volumn 48, Issue 4, 2013, Pages 604-622

  Klein, Christopher J ^a   Duan, Xiaohui ^a,b   Shy, Michael E ^c  

^a MAYO CLINIC   (United States)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Ataxia; Cerebellum; Neuropathy; Spinocerebellar; Triplet repeats

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; DNA METHYLTRANSFERASE 1; EARLY GROWTH RESPONSE FACTOR 2; GAP JUNCTION PROTEIN BETA 1; GLYCINE TRANSFER RNA LIGASE; HEAT SHOCK PROTEIN 22; HEAT SHOCK PROTEIN 27; IMMUNOGLOBULIN M; MITOFUSIN 2; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN PROTEIN; MYELIN PROTEIN ZERO; PERIPHERAL MYELIN PROTEIN 22; PROTEIN; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 4;

ACTION POTENTIAL; AMYLOIDOSIS; ANKLE FRACTURE; ANKLE SPRAIN; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; AUTOSOMAL RECESSIVE INHERITANCE; BRACHIAL PLEXUS NEUROPATHY; DEMYELINATING NEUROPATHY; DIABETIC NEUROPATHY; DISTAL HEREDITARY MOTOR NEUROPATHY; ELECTROMYOGRAPHY; FAMILIAL AMYLOID POLYNEUROPATHY; FAMILY HISTORY; FOOT FRACTURE; FRIEDREICH ATAXIA; GENETIC HETEROGENEITY; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HEREDITARY BRACHIAL PLEXUS NEUROPATHY; HEREDITARY MOTOR SENSORY NEUROPATHY; HEREDITARY NEUROPATHY WITH PRESSURE PALSY; HISTOPATHOLOGY; HUMAN; INHERITANCE; INHERITED NEUROPATHY; KENNEDY DISEASE; MISSENSE MUTATION; MONOCLONAL IMMUNOGLOBULINEMIA; MOTOR NERVE CONDUCTION; MOTOR NEUROPATHY; MOTOR UNIT POTENTIAL; NERVE BIOPSY; NERVE CONDUCTION; NERVE FIBER TRANSPORT; NEUROPATHY; POEMS SYNDROME; PRIORITY JOURNAL; PROGNOSIS; SCHWANN CELL; SENSORY NERVE CELL; SILVER RUSSELL SYNDROME; SKIN BIOPSY; SPINOCEREBELLAR DEGENERATION; SURAL NERVE; CENTRAL NERVOUS SYSTEM DISEASES; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; GENETICS; PERIPHERAL NERVOUS SYSTEM DISEASES;

CENTRAL NERVOUS SYSTEM DISEASES; DIAGNOSIS, DIFFERENTIAL; HUMANS; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 84901239533     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23775     Document Type: Article

References (108)

1. Dyck PJ, Oviatt KF, Lambert EH. Intensive evaluation of unclassified neuropathies yields improved diagnosis. Ann Neurol 1981;10:222-226.
2. Chahin N, Zeldenrust SR, Amrami KK, Engelstad JK, Dyck PJ. Two causes of demyelinating neuropathy in one patient: CMT1A and POEMS syndrome. Can J Neurol Sci 2007;34:380-385.
3. Chaudhry V, Chaudhry M, Crawford TO, Simmons-O'Brien E, Griffin JW. Toxic neuropathy in patients with pre-existing neuropathy. Neurology 2003;60:337-340.
4. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993;43:817-824.
5. Triggs WJ, Brown RH Jr, Menkes DL. Case records of the Massachusetts General Hospital. Case 18-2006. A 57-year-old woman with numbness and weakness of the feet and legs. N Engl J Med 2006;354:2584-2592.
6. Kilfoyle DH, Dyck PJ, Wu Y, Litchy WJ, Klein DM, Kumar N, et al. Myelin protein zero mutation His39Pro: hereditary motor and sensory neuropathy with variable onset, hearing loss, restless legs and multiple sclerosis. J Neurol Neurosurg Psychiatry 2006;77:963-966.
7. Laura M, Milani M, Morbin M, Moggio M, Ripolone M, Jann S, et al. Rapid progression of late onset axonal Charcot-Marie-Tooth disease associated with a novel MPZ mutation in the extracellular domain. J Neurol Neurosurg Psychiatry 2007;78:1263-1266.
8. Burns TM, Phillips LH II, Dimberg EL, Vaught BK, Klein CJ. Novel myelin protein zero mutation (Arg36Trp) in a patient with acute onset painful neuropathy. Neuromuscul Disord 2006;16:308-310.
9. Auer-Grumbach M, Strasser-Fuchs S, Robl T, Windpassinger C, Wagner K. Late onset Charcot-Marie-Tooth 2 syndrome caused by two novel mutations in the MPZ gene. Neurology 2003;61:1435-1437.
10. Klein CJ, Wu Y, Cunningham JM, Windebank AJ, Dyck PJB, Friedenberg SM, et al. SEPT9 mutations and a conserved 17q25 sequence in sporadic and hereditary brachial plexus neuropathy. Arch Neurol 2009;66:238-243.
11. Klein CJ, Dyck PJ, Friedenberg SM, Burns TM, Windebank AJ. Inflammation and neuropathic attacks in hereditary brachial plexus neuropathy. J Neurol Neurosurg Psychiatry 2002;73:45-50.
12. Sinnreich M, Sorenson EJ, Klein CJ. Neurologic course, endocrine dysfunction and triplet repeat size in spinal bulbar muscular atrophy. Can J Neurol Sci 2004;31:378-382.
13. Amato AA, Prior TW, Barohn RJ, Snyder P, Papp A, Mendell JR. Kennedy's disease: a clinicopathologic correlation with mutations in the androgen receptor gene. Neurology 1993;43:791-794.
14. Bennett CL, Lawson VH, Brickell KL, Isaacs K, Seltzer W, Lipe HP, et al. Late-onset hereditary axonal neuropathies. Neurology 2008;71:14-20.
15. La Pean A, Jeffries N, Grow C, Ravina B, Di Prospero NA. Predictors of progression in patients with Friedreich ataxia. Mov Disord 2008;23:2026-2032.
16. Schmitz-Hubsch T, Coudert M, Bauer P, Giunti P, Globas C, Baliko L, et al. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology 2008;71:982-989.
17. Klein CJ, Cunningham JM, Atkinson EJ, Schaid DJ, Hebbring SJ, Anderson SA, et al. The gene for HMSN2C maps to 12q23-24: a region of neuromuscular disorders. Neurology 2003;60:1151-1156.
18. Dyck PJ, O'Brien PC, Litchy WJ, Harper CM, Daube JR. Use of percentiles and normal deviates to express nerve conduction and other test abnormalities. Muscle Nerve 2001;24:307-310.
19. Lewis RA, Sumner AJ. The electrodiagnostic distinctions between chronic familial and acquired demyelinative neuropathies. Neurology 1982;32:592-596.
20. Gutierrez A, England JD, Sumner AJ, Ferer S, Warner LE, Lupski JR, et al. Unusual electrophysiological findings in X-linked dominant Charcot-Marie-Tooth disease. Muscle Nerve 2000;23:182-188.
21. Lewis RA, Sumner AJ. Electrophysiologic features of inherited demyelinating neuropathies: a reappraisal. Ann NY Acad Sci 1999;883:321-335.
22. Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 2006;354:1362-1369.
23. Garces-Sanchez M, Dyck PJ, Kyle RA, Zeldenrust S, Wu Y, Ladha SS, et al. Antibodies to myelin-associated glycoprotein (anti-Mag) in IgM amyloidosis may influence expression of neuropathy in rare patients. Muscle Nerve 2008;37:490-495.
24. Lupu VD, Mora CA, Dambrosia J, Meer J, Dalakas M, Floeter MK. Terminal latency index in neuropathy with antibodies against myelin-associated glycoproteins. Muscle Nerve 2007;35:196-202.
25. Dyck PJ, Lambert EH. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy: I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. Arch Neurol 1968;18:603-618.
26. Saporta AS, Sottile SL, Miller LJ, Feely SM, Siskind CE, Shy ME. Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Ann Neurol 2011;69:22-33.
27. Dyck PJ, Karnes JL, Lambert EH. Longitudinal study of neuropathic deficits and nerve conduction abnormalities in hereditary motor and sensory neuropathy type 1. Neurology 1989;39:1302-1308.
28. Low PA. Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure. Mayo Clin Proc 1993;68:748-752.
29. Mauermann M, Klein C. Hereditary sensory and autonomic neuropathies and miscellaneous inherited neuropathies with autonomic involvement. In: Bennaroch EE, Low PA, editors. Clinical autonomic disorders, 3rd ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2008. p 468-481.
30. Dyck P, O'Brien P, Johnson D, Klein C, Dyck P. Quantitative sensation testing. In: Dyck PT, editor. Peripheral neuropathy, 4th ed. Vol. 1. Part IX. Philadelphia: Elsevier Saunders; 2005. p 1063-1093.
31. Pelosi L, Lanzillo B, Perretti A, Santoro L, Blumhardt L, Caruso G. Motor and somatosensory evoked potentials in hereditary spastic paraplegia. J Neurol Neurosurg Psychiatry 1991;54:1099-1102.
32. Abele M, Burk K, Andres F, Topka H, Laccone F, Bosch S, et al. Autosomal dominant cerebellar ataxia type I. Nerve conduction and evoked potential studies in families with SCA1, SCA2 and SCA3. Brain 1997;120:2141-2148.
33. Klein CJ, Kimmel GW, Pittock SJ, Engelstad JE, Cunningham JM, Wu Y, et al. Large kindred evaluation of mitofusin 2 novel mutation, extremes of neurologic presentations, and preserved nerve mitochondria. Arch Neurol 2011;68:1295-1302.
34. Klein CJ, Vrana JA, Theis JD, Dyck PJ, Spinner RJ, Mauermann ML, et al. Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue. Arch Neurol 2011;68:195-199.
35. Verze L, Viglietti-Panzica C, Plumari L, Calcagni M, Stella M, Schrama LH, et al. Cutaneous innervation in hereditary sensory and autonomic neuropathy type IV. Neurology 2000;55:126-128.
36. Li J, Bai Y, Ghandour K, Qin P, Grandis M, Trostinskaia A, et al. Skin biopsies in myelin-related neuropathies: bringing molecular pathology to the bedside. Brain 2005;128:1168-1177.
37. Katona I, Wu X, Feely SM, Sottile S, Siskind CE, Miller LJ, et al. PMP22 expression in dermal nerve myelin from patients with CMT1A. Brain 2009;132:1734-1740.
38. Saporta MA, Katona I, Lewis RA, Masse S, Shy ME, Li J. Shortened internodal length of dermal myelinated nerve fibres in Charcot-Marie-Tooth disease type 1A. Brain 2009;132:3263-3273.
39. Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin Genet 1974;6:98-118.
40. Martyn CN, Hughes RA. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry 1997;62:310-318.
41. Dyck PJ. Changing concepts, differential diagnosis, and classificiation. Med Clin N Am 1968;42:895-908.
42. Houlden H, Laura M, Ginsberg L, Jungbluth H, Robb SA, Blake J, et al. The phenotype of Charcot-Marie-Tooth disease type 4C due to SH3TC2 mutations and possible predisposition to an inflammatory neuropathy. Neuromuscul Disord 2009;19:264-269.
43. Fink JK. The hereditary spastic paraplegias: nine genes and counting. Arch Neurol 2003;60:1045-1049.
44. Zuchner S, de Jonghe P, Jordanova A, Claeys KG, Guergueltcheva V, Cherninkova S, et al. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. Ann Neurol 2006;59:276-281.
45. Chung KW, Kim SB, Park KD, Choi KG, Lee JH, Eun HW, et al. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations. Brain 2006;129:2103-2118.
46. Windebank A. Inherited recurrent focal neuropathies. In: Dyck PJ, Low PA, Poduslo JF, editors. Peripheral neuropathy, 3rd ed. Vol. 2. Philadelphia: Saunders; 1993. p 1137-1160.
47. England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, et al. Evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Muscle Nerve 2009;39:116-125.
48. Blair IP, Nash J, Gordon MJ, Nicholson GA. Prevalence and origin of de novo duplications in Charcot-Marie-Tooth disease type 1A: first report of a de novo duplication with a maternal origin. Am J Hum Gen 1996;58:472-476.
49. Feely SM, Laura M, Siskind CE, Sottile S, Davis M, Gibbons VS, et al. MFN2 mutations cause severe phenotypes in most patients with CMT2A. Neurology 2011;76:1690-1696.
50. Murphy SM, Laura M, Fawcett K, Pandraud A, Liu YT, Davidson GL, et al. Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing. J Neurol Neurosurg Psychiatry 2012;83:706-710.
51. Latour P, Vial C. Molecular diagnosis of axonal forms of Charcot-Marie-Tooth disease [in French]. Rev Neurol (Paris) 2009;165:1122-1126.
52. Dubourg O, Azzedine H, Verny C, Durosier G, Birouk N, Gouider R, et al. Autosomal-recessive forms of demyelinating Charcot-Marie-Tooth disease. Neuromol Med 2006;8:75-86.
53. Klein CJ, Dyck P. Hereditary sensory and autonomic neuropathies (HSAN): clinical features pathologic classification, and molecular genetics. In: Dyck PJ, editor. Peripheral neuropathy, 4th ed. Vol. 2. Elsevier; 2005. p 1809-1845.
54. Rotthier A, Penno A, Rautenstrauss B, Auer-Grumbach M, Stettner GM, Asselbergh B, et al. Characterization of two mutations in the SPTLC1 subunit of serine palmitoyltransferase associated with hereditary sensory and autonomic neuropathy type I. Hum Mut 2011;32:E2211-2225.
55. Rotthier A, Baets J, de Vriendt E, Jacobs A, Auer-Grumbach M, Levy N, et al. Genes for hereditary sensory and autonomic neuropathies: a genotype-phenotype correlation. Brain 2009;132:2699-2711.
56. Rotthier A, Baets J, Timmerman V, Janssens K. Mechanisms of disease in hereditary sensory and autonomic neuropathies. Nat Rev Neurol 2012;8:73-85.
57. Klein CJ, Botuyan M-V, Wu Y, Ward CJ, Nicholson GA, Hammans S, et al. Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat Genet 2011;43:595-600.
58. Winkelmann J, Lin L, Schormair B, Kornum BR, Faraco J, Plazzi G, et al. Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy. Hum Mol Genet 2012;21:2205-2210.
59. Roddier K, Thomas T, Marleau G, Gagnon AM, Dicaire MJ, et al. Two mutations in the HSN2 gene explain the high prevalence of HSAN2 in French Canadians. Neurology 2005;64:1762-1767.
60. Kurth I, Pamminger T, Hennings JC, Soehendra D, Huebner AK, Rotthier A, et al. Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy. Nat Genet 2009;41:1179-1181.
61. Riviere JB, Ramalingam S, Lavastre V, Shekarabi M, Holbert S, Lafontaine J, et al. KIF1A, an axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2. Am J Hum Genet 2011;89:219-230.
62. Gold-von Simson G, Axelrod FB. Familial dysautonomia: update and recent advances. Curr Probl Pediatr Adolesc Health Care 2006;36:218-237.
63. Indo Y, Tsuruta M, Hayashida Y, Karim MA, Ohta K, Kawano T, et al. Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis. Nat Genet 1996;13:485-488.
64. Einarsdottir E, Carlsson A, Minde J, Toolanen G, Svensson O, Solders G, et al. A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception. Hum Mol Genet 2004;13:799-805.
65. Carvalho OP, Thornton GK, Hertecant J, Houlden H, Nicholas AK, Cox JJ, et al. A novel NGF mutation clarifies the molecular mechanism and extends the phenotypic spectrum of the HSAN5 neuropathy. J Med Genet 2011;48:131-135.
66. Indo Y. Genetics of congenital insensitivity to pain with anhidrosis (CIPA) or hereditary sensory and autonomic neuropathy type IV. Clinical, biological and molecular aspects of mutations in TRKA(NTRK1) gene encoding the receptor tyrosine kinase for nerve growth factor. Clin Auton Res 2002;12(suppl 1):I20-32.
67. Dyck PJ, Mellinger JF, Reagan TJ, Horowitz SJ, McDonald JW, Litchy WJ, et al. Not 'indifference to pain' but varieties of hereditary sensory and autonomic neuropathy. Brain 1983;106:373-390.
68. Waxman SG. Neuroscience: channelopathies have many faces. Nature 2011;472:173-174.
69. Davis MD, Weenig RH, Genebriera J, Wendelschafer-Crabb G, Kennedy WR, Sandroni P. Histopathologic findings in primary erythromelalgia are nonspecific: special studies show a decrease in small nerve fiber density. J Am Acad Dermatol 2006;55:519-522.
70. Davis MD, Sandroni P, Rooke TW, Low PA. Erythromelalgia: vasculopathy, neuropathy, or both? A prospective study of vascular and neurophysiologic studies in erythromelalgia. Arch Dermatol 2003;139:1337-1343.
71. Faber CG, Hoeijmakers JG, Ahn HS, Cheng X, Han C, Choi JS, et al. Gain of function Na(V) 1.7 mutations in idiopathic small fiber neuropathy. Ann Neurol 2012;71:26-39.
72. Auer-Grumbach M, de Jonghe P, Wagner K, Verhoeven K, Hartung HP, Timmerman V. Phenotype-genotype correlations in a CMT2B family with refined 3q13-q22 locus. Neurology 2000;55: 1552-1557.
73. Bouhouche A, Benomar A, Bouslam N, Chkili T, Yahyaoui M. Mutation in the epsilon subunit of the cytosolic chaperonin-containing t-complex peptide-1 (Cct5) gene causes autosomal recessive mutilating sensory neuropathy with spastic paraplegia. J Med Genet 2006;43:441-443.
74. Guelly C, Zhu PP, Leonardis L, Papic L, Zidar J, Schabhuttl M, et al. Targeted high-throughput sequencing identifies mutations in atlastin-1 as a cause of hereditary sensory neuropathy type I. Am J Hum Genet 2011;88:99-105.
75. Irobi J, van Impe K, Seeman P, Jordanova A, Dierick I, Verpoorten N, et al. Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. Nat Genet 2004;36:597-601.
76. Tang BS, Zhao GH, Luo W, Xia K, Cai F, Pan Q, et al. Small heat-shock protein 22 mutated in autosomal dominant Charcot-Marie-Tooth disease type 2L. Hum Genet 2005;116:222-224.
77. Deng HX, Klein CJ, Yan J, Shi Y, Wu Y, Fecto F, et al. Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4. Nat Genet 2010;42:165-169.
78. Landoure G, Zdebik AA, Martinez TL, Burnett BG, Stanescu HC, Inada H, et al. Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C. Nat Genet 2010;42:170-174.
79. Auer-Grumbach M, Olschewski A, Papic L, Kremer H, McEntagart ME, Uhrig S, et al. Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C. Nat Genet 2010;42:160-164.
80. Zimon M, Baets J, Auer-Grumbach M, Berciano J, Garcia A, Lopez-Laso E, et al. Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies. Brain 2010:1798-1809.
81. Antonellis A, Ellsworth RE, Sambuughin N, Puls I, Abel A, Lee-Lin SQ, et al. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet 2003;72:1293-1299.
82. Dierick I, Baets J, Irobi J, Jacobs A, De Vriendt E, Deconinck T, et al. Relative contribution of mutations in genes for autosomal dominant distal hereditary motor neuropathies: a genotype-phenotype correlation study. Brain 2008;131:1217-1227.
83. Pitt M, Houlden H, Jacobs J, Mok Q, Harding B, Reilly M, et al. Severe infantile neuropathy with diaphragmatic weakness and its relationship to SMARD1. Brain 2003;126:2682-2692.
84. Guenther UP, Handoko L, Laggerbauer B, Jablonka S, Chari A, Alzheimer M, et al. IGHMBP2 is a ribosome-associated helicase inactive in the neuromuscular disorder distal SMA type 1 (DSMA1). Hum Mol Genet 2009;18:1288-1300.
85. Zhao ZH, Chen WZ, Wu ZY, Wang N, Zhao GX, Chen WJ, et al. A novel mutation in the senataxin gene identified in a Chinese patient with sporadic amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2009;10:118-122.
86. de Jonghe P, Auer-Grumbach M, Irobi J, Wagner K, Plecko B, Kennerson M, et al. Autosomal dominant juvenile amyotrophic lateral sclerosis and distal hereditary motor neuronopathy with pyramidal tract signs: synonyms for the same disorder? Brain 2002;125:1320-1325.
87. Moreira MC, Klur S, Watanabe M, Nemeth AH, Le Ber I, Moniz JC, et al. Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2. Nat Genet 2004;36:225-227.
88. Windpassinger C, Auer-Grumbach M, Irobi J, Patel H, Petek E, Horl G, et al. Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome. Nat Genet 2004;36:271-276.
89. Klein CJ, Shi Y, Fecto F, Donaghy M, Nicholson G, McEntagart ME, et al. TRPV4 mutations and cytotoxic hypercalcemia in axonal Charcot-Marie-Tooth neuropathies. Neurology 2011;76:887-894.
90. van Alfen N. Clinical and pathophysiological concepts of neuralgic amyotrophy. Nat Rev Neurol 2011;7:315-322.
91. Klein CJ, Windebank AJ. Hereditary brachial plexus neuropathy. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy, 4th ed. Philadelphia: Elsevier; 2005. p 1753-1767.
92. Hannibal MC, Ruzzo EK, Miller LR, Betz B, Buchan JG, Knutzen DM, et al. SEPT9 gene sequencing analysis reveals recurrent mutations in hereditary neuralgic amyotrophy. Neurology 2009;72:1755-1759.
93. van Alfen N, van Engelen BG. The clinical spectrum of neuralgic amyotrophy in 246 cases. Brain 2006;129:438-450.
94. Landsverk ML, Ruzzo EK, Mefford HC, Buysse K, Buchan JG, Eichler EE, et al. Duplication within the SEPT9 gene associated with a founder effect in North American families with hereditary neuralgic amyotrophy. Hum Mol Genet 2009;18:1200-1208.
95. Kuhlenbaumer G, Hannibal MC, Nelis E, Schirmacher A, Verpoorten N, Meuleman J, et al. Mutations in SEPT9 cause hereditary neuralgic amyotrophy. Nat Genet 2005;37:1044-1046.
96. Klein CJ, Barbara DW, Sprung J, Dyck PJ, Weingarten TN. Surgical and postpartum hereditary brachial plexus attacks and prophylactic immunotherapy. Muscle Nerve 2013;47:23-27.
97. Bird TD. The hereditary ataxias; GeneReviews; 2012, http://www.ncbi.nlm.nih.gov/sites/GeneTests/review.
98. Graves TD, Guiloff RJ. SCA3 presenting as an isolated axonal polyneuropathy. Arch Neurol 2011;68:653-655.
99. Alper G, Narayanan V. Friedreich's ataxia. Pediatr Neurol 2003;28: 335-341.
100. Blackstone C. Cellular pathways of hereditary spastic paraplegia. Annu Rev Neurosci 2012;35:25-47.
101. Burns TM, Ryan MM, Darras B, Jones HR Jr. Current therapeutic strategies for patients with polyneuropathies secondary to inherited metabolic disorders. Mayo Clin Proc 2003;78:858-868.
102. Klein CJ. The inherited neuropathies. Neurol Clin 2007;25:173-207.
103. Pareyson D, Reilly MM, Schenone A, Fabrizi GM, Cavallaro T, Santoro L, et al. Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. Lancet Neurol 2011;10:320-328.
104. Garofalo K, Penno A, Schmidt BP, Lee HJ, Frosch MP, von Eckardstein A, et al. Oral l-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1. J Clin Invest 2011;121:4735-4745.
105. Scherer SS. The debut of a rational treatment for an inherited neuropathy? J Clin Invest 2011;121:4624-4627.
106. Edvardson S, Cinnamon Y, Jalas C, Shaag A, Maayan C, Axelrod FB, et al. Hereditary sensory autonomic neuropathy caused by a mutation in dystonin. Ann Neurol 2012;71:569-572.
107. Leonardis L, Auer-Grumbach M, Papic L, Zidar J. The N355K atlastin 1 mutation is associated with hereditary sensory neuropathy and pyramidal tract features. Eur J Neurol 2012;19:992-998.
108. Rotthier A, Baets J, De Vriendt E, Jacobs A, Auer-Grumbach M, Levy N, et al. Genes for hereditary sensory and autonomic neuropathies: a genotype-phenotype correlation. Brain 2009;132:2699-2711.